What is it about?
In hour-long interviews, thirty women over 65 were asked to reflect on their experiences of menopause and their decisions to use menopausal hormone therapy. All of them believed they benefitted from ongoing therapy, risks were rarely mentioned, and none had plans to quit. Doctors had been influential in convincing them to start hormones; however, these women were the main drivers of continued use.
Photo by Susan G. Komen 3-Day on Unsplash
Why is it important?
When users of menopausal hormone therapy believe it keeps them youthful and helps prevent disease, they fear quitting. Long-term therapy is associated with increased risks for breast and ovarian cancer, cardiovascular disease, cognitive decline, and incontinence. These risks are greater over time.
Read the Original
This page is a summary of: "I’m going to stay young": Belief in anti-aging efficacy of menopausal hormone therapy drives prolonged use despite medical risks, PLoS ONE, May 2020, PLOS, DOI: 10.1371/journal.pone.0233703.
You can read the full text:
The following have contributed to this page